Cpmg Inc - Net Worth and Insider Trading
Cpmg Inc Net Worth
The estimated net worth of Cpmg Inc is at least $1.5 Billion dollars as of 2024-12-27. Cpmg Inc is the 10% Owner of PROCEPT BioRobotics Corp and owns about 11,222,662 shares of PROCEPT BioRobotics Corp (PRCT) stock worth over $937 Million. Cpmg Inc is the Director, 10% Owner of Reata Pharmaceuticals Inc and owns about 3,063,567 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $528 Million. Cpmg Inc is also the 10% Owner of Apollo Endosurgery Inc and owns about 3,878,742 shares of Apollo Endosurgery Inc (APEN) stock worth over $39 Million. Details can be seen in Cpmg Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cpmg Inc has not made any transactions after 2021-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cpmg Inc
Cpmg Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cpmg Inc owns 4 companies in total, including Apollo Endosurgery Inc (APEN) , Reata Pharmaceuticals Inc (RETA) , and Genitope Corp (GTOPQ) among others .
Click here to see the complete history of Cpmg Inc’s form 4 insider trades.
Insider Ownership Summary of Cpmg Inc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APEN | Apollo Endosurgery Inc | 2021-10-15 | 10 percent owner |
| RETA | Reata Pharmaceuticals Inc | 2019-11-18 | director & 10 percent owner |
| GTOPQ | Genitope Corp | 2008-12-10 | other: Former 10% Owner |
 | | 2022-03-17 | 10 percent owner |
Cpmg Inc Latest Holdings Summary
Cpmg Inc currently owns a total of 3 stocks. Among these stocks, Cpmg Inc owns 11,222,662 shares of PROCEPT BioRobotics Corp (PRCT) as of September 17, 2021, with a value of $937 Million and a weighting of 62.32%. Cpmg Inc owns 3,063,567 shares of Reata Pharmaceuticals Inc (RETA) as of November 18, 2019, with a value of $528 Million and a weighting of 35.1%. Cpmg Inc also owns 3,878,742 shares of Apollo Endosurgery Inc (APEN) as of October 15, 2021, with a value of $39 Million and a weighting of 2.58%.
Latest Holdings of Cpmg Inc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRCT | PROCEPT BioRobotics Corp | 2021-09-17 | 11,222,662 | 83.53 | 937,428,957 |
| RETA | Reata Pharmaceuticals Inc | 2019-11-18 | 3,063,567 | 172.36 | 528,036,408 |
| APEN | Apollo Endosurgery Inc | 2021-10-15 | 3,878,742 | 10.00 | 38,787,420 |
Holding Weightings of Cpmg Inc
Cpmg Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Cpmg Inc has made a total of 1 transactions in PROCEPT BioRobotics Corp (PRCT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in PROCEPT BioRobotics Corp is the acquisition of 440,000 shares on September 17, 2021, which cost Cpmg Inc around $11 Million.
According to the SEC Form 4 filings, Cpmg Inc has made a total of 0 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years. The most-recent trade in Reata Pharmaceuticals Inc is the acquisition of 40,218 shares on November 18, 2019, which cost Cpmg Inc around $7 Million.
According to the SEC Form 4 filings, Cpmg Inc has made a total of 2 transactions in Apollo Endosurgery Inc (APEN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Apollo Endosurgery Inc is the acquisition of 683,871 shares on October 15, 2021, which cost Cpmg Inc around $5 Million.
Insider Trading History of Cpmg Inc
- 1
Cpmg Inc Trading Performance
GuruFocus tracks the stock performance after each of Cpmg Inc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cpmg Inc is 14.44%. GuruFocus also compares Cpmg Inc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cpmg Inc within 3 months outperforms 12 times out of 19 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cpmg Inc's insider trading performs compared to the benchmark.
Performance of Cpmg Inc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.55 | | | | | |
| Relative Return to S&P 500(%) | 11.07 | | | | | |
Cpmg Inc Ownership Network
Cpmg Inc Owned Company Details
What does Apollo Endosurgery Inc do?
Who are the key executives at Apollo Endosurgery Inc?
Cpmg Inc is the 10 percent owner of Apollo Endosurgery Inc. Other key executives at Apollo Endosurgery Inc include 10 percent owner Antal Rohit Desai , Chief Financial Officer Jeffrey G. Black , and VP & Int'l Sales and Marketing Mike Gutteridge .
Apollo Endosurgery Inc (APEN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Apollo Endosurgery Inc (APEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Apollo Endosurgery Inc (APEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Apollo Endosurgery Inc (APEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apollo Endosurgery Inc Insider Transactions
Cpmg Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Cpmg Inc. You might contact Cpmg Inc via mailing address: 4215 West Lovers Lane, Suite 100, Dallas Tx 75209.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
